D Russell-Jones, R Khan - Diabetes Obesity and Metabolism, 2007 - interscience.wiley.com Insulin therapy or intensification of insulin therapy commonly results in weight
gain in both type 1 and type 2 diabetes. This weight gain can be excessive,
adversely affecting cardiovascular risk profile. The spectre of weight gain ... Cited by 30 - Related articles - BL Direct - All 3 versions
B Balas, R Belfort, SA Harrison, C Darland, J … - Journal of Hepatology, 2007 - Elsevier Non-Alcoholic Steatohepatitis (NASH) is a chronic liver disease frequently
associated with insulin resistance and type 2 diabetes mellitus (T2DM).
Pioglitazone reverses the metabolic and histological abnormalities of ... Cited by 22 - Related articles - All 8 versions
CV Rizos, EN Liberopoulos, DP Mikhailidis, … - Expert Opin. Pharmacother., 2008 - informahealthcare.com Background: Insulin resistance and hyperglycemia characterize type 2 diabetes
mellitus. Type 2 diabetes mellitus is usually accompanied by concomitant
disorders, such as dyslipidemia, hypertension and atherosclerosis. ... Cited by 18 - Related articles - BL Direct - All 6 versions
CJ Tack, P Smits - Neth J Med, 2006 - njmonline.nl Pioglitazone and rosiglitazone, two oral blood glucose lowering drugs for the
treatment of type 2 diabetes mellitus, have been marketed in the Netherlands
since 2000. Both belong to the class of thiazolidinedione derivatives ... Cited by 16 - Related articles - View as HTML - All 7 versions
M Dorkhan, M Magnusson, A Frid, A Grubb, L … - Journal of internal medicine, 2006 - pt.wkhealth.com Correspondence: Mozhgan Dorkhan, Division of Diabetes & Endocrinology,
Department of Clinical Sciences, Malmö University Hospital, Lund University,
Malmö, S-20502 Sweden. (fax: +46 40 336201; e-mail: mozhgan.dorkhan@med.lu. ... Cited by 15 - Related articles - BL Direct - All 5 versions
J Karalliedde, RE Buckingham - Drug Safety, 2007 - ingentaconnect.com Thiazolidinediones (TZDs) or glitazones are agents that are widely used for the
Abstract treatment of type 2 diabetes mellitus. These drugs have a multitude of
therapeutic effects including reduction in insulin resistance and ... Cited by 15 - Related articles - BL Direct - All 6 versions
R Berria, L Glass, A Mahankali, Y Miyazaki, A … - Clinical Pharmacology & Therapeutics, 2007 - nature.com Peripheral edema, mild weight gain, and anemia are often observed in type II
diabetic patients treated with thiazolidinediones (TZDs). Small decreases in
hemoglobin (Hb) and hematocrit (Hct) appear to be a class effect of TZDs ... Cited by 13 - Related articles - All 3 versions
TD Giles, AB Miller, U Elkayam, M … - Journal of cardiac failure, 2008 - urielkayam.com THOMAS D. GILES, MD,1 ALAN B. MILLER, MD,2 URI ELKAYAM, MD,3 MONDIRA
BHATTACHARYA, MD,4 AND ALFONSO PEREZ, MD4 ... New Orleans, Louisiana;
Jacksonville, Florida; Los Angeles, California; Deerfield, Illinois Cited by 9 - Related articles - View as HTML - All 23 versions
